Pipeline

Cidara’s pipeline is comprised of new approaches aimed at transforming existing treatment and prevention paradigms, first with once-weekly lead antifungal candidate, rezafungin, followed by highly potent, long-acting drug-Fc conjugates (DFCs) from its proprietary Cloudbreak® platform that target viral and oncology disease areas.